ATE137505T1 - Schützende antikörper erregende plasmodium falciparum antigene und deren verwendung in impfstoffen - Google Patents
Schützende antikörper erregende plasmodium falciparum antigene und deren verwendung in impfstoffenInfo
- Publication number
- ATE137505T1 ATE137505T1 AT91914543T AT91914543T ATE137505T1 AT E137505 T1 ATE137505 T1 AT E137505T1 AT 91914543 T AT91914543 T AT 91914543T AT 91914543 T AT91914543 T AT 91914543T AT E137505 T1 ATE137505 T1 AT E137505T1
- Authority
- AT
- Austria
- Prior art keywords
- code
- vaccines
- exciting
- plasmodium falciparum
- protective antibodies
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 241000223960 Plasmodium falciparum Species 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 5
- 125000003729 nucleotide group Chemical group 0.000 abstract 5
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- QUAWOKPCAKCHQL-SRVKXCTJSA-N Asn-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N QUAWOKPCAKCHQL-SRVKXCTJSA-N 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9010039A FR2665365B1 (fr) | 1990-08-06 | 1990-08-06 | Antigene de plasmodium falciparum susceptible d'induire des anticorps protecteurs - application a la vaccination. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE137505T1 true ATE137505T1 (de) | 1996-05-15 |
Family
ID=9399464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91914543T ATE137505T1 (de) | 1990-08-06 | 1991-08-01 | Schützende antikörper erregende plasmodium falciparum antigene und deren verwendung in impfstoffen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0542845B1 (de) |
| AT (1) | ATE137505T1 (de) |
| CA (1) | CA2088988A1 (de) |
| DE (1) | DE69119230D1 (de) |
| FR (1) | FR2665365B1 (de) |
| WO (1) | WO1992002549A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679776A1 (fr) * | 1991-07-31 | 1993-02-05 | Pasteur Institut | Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum. |
| EP0602079A1 (de) * | 1991-07-31 | 1994-06-22 | Institut Pasteur | Gegen p. falciparum merozoiten aktiven antikörpern indunierende polypeptide |
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| EP2958238A1 (de) | 2014-06-17 | 2015-12-23 | Thomson Licensing | Verfahren und Vorrichtung zur Codierung von Informationseinheiten in Codewort-Sequenzen unter Vermeidung von Umkehrkomplementarität |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984002472A1 (fr) * | 1982-12-27 | 1984-07-05 | Pasteur Institut | Fractions polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogenes les contenant |
| FR2610631B1 (fr) * | 1987-02-09 | 1989-11-24 | Pasteur Institut | Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme |
-
1990
- 1990-08-06 FR FR9010039A patent/FR2665365B1/fr not_active Expired - Fee Related
-
1991
- 1991-08-01 CA CA002088988A patent/CA2088988A1/fr not_active Abandoned
- 1991-08-01 EP EP91914543A patent/EP0542845B1/de not_active Expired - Lifetime
- 1991-08-01 AT AT91914543T patent/ATE137505T1/de not_active IP Right Cessation
- 1991-08-01 DE DE69119230T patent/DE69119230D1/de not_active Expired - Lifetime
- 1991-08-01 WO PCT/FR1991/000639 patent/WO1992002549A1/fr active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP0542845B1 (de) | 1996-05-01 |
| EP0542845A1 (de) | 1993-05-26 |
| DE69119230D1 (de) | 1996-06-05 |
| FR2665365A1 (fr) | 1992-02-07 |
| WO1992002549A1 (fr) | 1992-02-20 |
| CA2088988A1 (fr) | 1992-02-07 |
| FR2665365B1 (fr) | 1995-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2329772A1 (en) | Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| EP1162272B8 (de) | Herstellung von einer Immunantwort gegen Prostat-spezifisches Antigen (PSA) | |
| NZ333431A (en) | Multiple epitope fusion protein selected from HIV or HCV, method of immunoassay and assay device | |
| ATE162550T1 (de) | Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene | |
| DK0425082T3 (da) | Vacciner | |
| IL75788A (en) | Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein | |
| ATE137505T1 (de) | Schützende antikörper erregende plasmodium falciparum antigene und deren verwendung in impfstoffen | |
| KR920002629A (ko) | B형 간염 코어 항원의 아미노산 잔기 서열 | |
| Zavala et al. | Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccine | |
| ES2006730A6 (es) | Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum | |
| GB2176191A (en) | Antigens of plasmodium falciparum | |
| ATE136586T1 (de) | Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten | |
| MY103217A (en) | Plasmodium falciparum merozoite antigen pertides | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| KR890000106A (ko) | 원생성 기생충 예방용 백신 | |
| ZA896942B (en) | Allelic variants of plasmodium falciparum merozoite surface antigen | |
| CA2370278A1 (en) | Chimeric lyssavirus nucleic acids and polypeptides | |
| IT1233419B (it) | Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| Dietzschold et al. | Synthesis of an antigenic determinant of the HSV gD that stimulates the induction of virus-neutralizing antibodies and confers protection against a lethal challenge of HSV. | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| Sarobe | Peptidos sinteticos en la induccion de la respuesta inmune humoral: Obtencion de anticuerpos neutralizantes frente al VIH-1. | |
| DK0388738T3 (da) | Plasmodium merozoit rhoptries-antigen og derivater | |
| DE69128095D1 (de) | Azelluläre impfstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |